R&D | June 01, 2026
International scientists say deuterium research could reshape medicine
The conference highlighted research suggesting that deuterium levels may influence key biological processes
The conference highlighted research suggesting that deuterium levels may influence key biological processes
Ariane brings a strong track record within Ardena, including her leadership of the company’s drug product division since 2022
First-in-human study of investigational SOS1 inhibitor shows encouraging safety profile and early anti-tumor activity in patients with metastatic solid tumors
The platform created by NIT Rourkela researchers is capable of delivering rapid, accurate, and repeatable imaging results with minimal human intervention
The newly licensed platform enables precise control over both the drug-to-antibody ratio and payload attachment sites in single- and dual-payload ADCs
The finance leader and investment banking veteran to steer global financial strategy, investor relations, and growth initiatives
In his new role, Shisher will lead Glenmark’s marketing initiatives, focusing on strengthening brand positioning, driving market expansion, and accelerating growth
Sarin will focus on advancing scalable AI-driven platforms and strengthening the company’s global data science capabilities across healthcare and enterprise technology domains
A one-shot gene-editing cholesterol therapy could soon be a reality
AAV vectors are widely used in gene therapy for their strong therapeutic potential
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
